# Levosimendan in Acute Kidney Injury Study

> **NCT01720030** · PHASE2,PHASE3 · UNKNOWN · sponsor: **VieCuri Medical Centre** · enrollment: 68 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Conventional therapy

## Key facts

- **NCT ID:** NCT01720030
- **Lead sponsor:** VieCuri Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2016-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720030, "Levosimendan in Acute Kidney Injury Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01720030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*